University Hospital Basel, Department of Endocrinology
Basel, Canton of Basel-City, 4031, Switzerland
NCT Number: NCT03269747
Interventional, Placebo controlled cross-over study to investigate the short-term effects of glucocorticoids (prednisone) on human brown adipose tissue.
Looking for future studies?
Notify Me18 year–40 year
Male
Interventional
Phase 4
Basel, Canton of Basel-City, 4031, Switzerland
Active brown adipose tissue (BAT) has recently been unambiguously discovered in human adults. Active BAT increases energy expenditure and improves glucose tolerance. Pharmacological use of glucocorticoids (GCs) is widespread in clinical practice due to their high anti-inflammatory efficacy. While short-term administration even of high doses usually is well tolerated, long-term use of medium to high amounts of GCs leads to unfavorable metabolic changes, characterized by an increase in intra-abdominal fat mass, a decrease in muscle mass and insulin resistance.
In line with these well-known side-effects of GCs, several in vitro studies and animal models demonstrate an inhibiting effect of GCs on BAT thermogenesis.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 tablets of Prednisone 20 Mg in the morning
2 Placebo tablets in the morning
Time frame: at the end of each treatment period (day 7). Prednisone vs. Placebo
: Increase in energy expenditure above resting metabolic rate in response to a mild cold stimulus determined by indirect calorimetry
Time frame: at the end of each treatment period (day 7). Prednisone vs. Placebo
determined by MRI
Time frame: at the end of each treatment period (day 7). Prednisone vs. Placebo
determined by MRI
Time frame: at the end of each treatment period (day 7). Prednisone vs. Placebo
determined as SUVmean by FDG-PET/CT
Time frame: at the end of each treatment period (day 7). Prednisone vs. Placebo
determined by FDG-PET/CT
Time frame: at the end of each treatment period (day 7). Prednisone vs. Placebo
Time frame: at the end of each treatment period (day 7). Prednisone vs. Placebo
Time frame: at the end of each treatment period (day 7). Prednisone vs. Placebo
University Hospital, Basel, Switzerland
Other
Acronym: GlucoBAT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06078345
Brown Adipose Tissue, Metabolic Disease
Basel, Switzerland
View Trial DetailsNCT02237872
Body Weight, Brown Adipose Tissue
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05711199
Brown Adipose Tissue
Basel, Canton of Basel-City, Switzerland
View Trial DetailsNCT05990387
Brown Adipose Tissue, Resting Energy Expenditure
Bloomington, Indiana, United States
View Trial Details